| Literature DB >> 31604679 |
Yujiao Zou1, Xian Lin2, Junguo Bu3, Zelong Lin2, Yanjuan Chen2, Yunhui Qiu2, Haiyue Mo2, Yao Tang2, Weiyi Fang4, Ziqing Wu5.
Abstract
MicroRNAs (miRNAs) play an essential role in the self-renewal of breast cancer stem cells (BCCs). Our study aimed to clarify the role of proto-oncogene c-Jun-regulated miR-5188 in breast cancer progression and its association with Timeless-mediated cancer stemness. In the present study, we showed that miR-5188 exerted an oncogenic effect by inducing breast cancer stemness, proliferation, metastasis, and chemoresistance in vitro and in vivo. The mechanistic analysis demonstrated that miR-5188 directly targeted FOXO1, which interacted with β-catenin in the cytoplasm, facilitated β-catenin degradation, and impaired the nuclear accumulation of β-catenin, thus stimulating the activation of known Wnt targets, epithelial-mesenchymal transition (EMT) markers, and key regulators of cancer stemness. Moreover, miR-5188 potentiated Wnt/β-catenin/c-Jun signaling to promote breast cancer progression. Interestingly, c-Jun enhanced miR-5188 transcription to form a positive regulatory loop, and Timeless interacted with Sp1/c-Jun to induce miR-5188 expression by promoting c-Jun-mediated transcription, which further activated miR-5188-FOXO1/β-catenin-c-Jun loop and facilitated breast cancer progression. Importantly, miR-5188 was upregulated in breast cancer and was positively correlated with poor patient prognosis. This study identifies miR-5188 as a novel oncomiR and provides a new theoretical basis for the clinical use of miR-5188 antagonists in the treatment of breast cancer.Entities:
Keywords: FOXO1; breast cancer; cancer stem cells; miR-5188; stemness; timeless; ubiquitination; β-catenin
Mesh:
Substances:
Year: 2019 PMID: 31604679 PMCID: PMC6951841 DOI: 10.1016/j.ymthe.2019.08.015
Source DB: PubMed Journal: Mol Ther ISSN: 1525-0016 Impact factor: 11.454